Your browser doesn't support javascript.
loading
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.
Spear, Timothy T; Riley, Timothy P; Lyons, Gretchen E; Callender, Glenda G; Roszkowski, Jeffrey J; Wang, Yuan; Simms, Patricia E; Scurti, Gina M; Foley, Kendra C; Murray, David C; Hellman, Lance M; McMahan, Rachel H; Iwashima, Makio; Garrett-Mayer, Elizabeth; Rosen, Hugo R; Baker, Brian M; Nishimura, Michael I.
Afiliação
  • Spear TT; Department of Surgery, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA; tspear@luc.edu.
  • Riley TP; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA;
  • Lyons GE; Department of Surgery, University of Chicago, Chicago, Illinois, USA; Department of Biology, Northeastern Illinois University, Chicago, Illinois, USA;
  • Callender GG; Department of Surgery, University of Chicago, Chicago, Illinois, USA; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA;
  • Roszkowski JJ; Department of Surgery, University of Chicago, Chicago, Illinois, USA;
  • Wang Y; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA;
  • Simms PE; Flow Cytometry Core Facility, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA;
  • Scurti GM; Department of Surgery, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA;
  • Foley KC; Department of Surgery, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA;
  • Murray DC; Department of Surgery, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA;
  • Hellman LM; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA;
  • McMahan RH; Division of Gastroenterology and Hepatology, Hepatitis C Center, and Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA; and.
  • Iwashima M; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA;
  • Garrett-Mayer E; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Rosen HR; Division of Gastroenterology and Hepatology, Hepatitis C Center, and Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA; and.
  • Baker BM; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA;
  • Nishimura MI; Department of Surgery, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA; Department of Surgery, University of Chicago, Chicago, Illinois, USA;
J Leukoc Biol ; 100(3): 545-57, 2016 09.
Article em En | MEDLINE | ID: mdl-26921345

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Antígenos de Histocompatibilidade Classe I / Hepatite C / Hepacivirus / Epitopos de Linfócito T / Instabilidade Genômica / Imunoterapia Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Antígenos de Histocompatibilidade Classe I / Hepatite C / Hepacivirus / Epitopos de Linfócito T / Instabilidade Genômica / Imunoterapia Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2016 Tipo de documento: Article